BFRI — Biofrontera Cashflow Statement
0.000.00%
Last trade - 00:00- $6.39m
- $4.58m
- $37.32m
- 40
- 58
- 30
- 38
Annual cashflow statement for Biofrontera, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -11 | -37.7 | -0.64 | -20.1 | -17.8 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.883 | 12 | -18.9 | -0.874 | 0.856 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.83 | -1.5 | 2.79 | -4.39 | 6.21 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -12.4 | -26.7 | -16.2 | -24.9 | -10.3 |
| Capital Expenditures | 0 | -0.011 | -0.038 | -0.005 | -0.06 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | — | -5.12 | 0.624 | 0.057 |
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | -0.011 | -5.16 | 0.619 | -0.003 |
| Financing Cash Flow Items | 4.4 | 0 | — | 21.4 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 13.2 | 43.2 | 14 | 8.41 | 14.8 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.825 | 16.5 | -7.33 | -15.9 | 4.56 |